Peptide receptor radionuclide therapy for neuroendocrine tumours: standardized and randomized, or personalized?

Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):211-3. doi: 10.1007/s00259-013-2621-6. Epub 2013 Nov 13.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Female
  • Humans
  • Male
  • Neuroendocrine Tumors / radiotherapy*
  • Octreotide / analogs & derivatives*
  • Octreotide / therapeutic use
  • Radiopharmaceuticals / therapeutic use*

Substances

  • 177Lu-octreotide, DOTA(0)-Tyr(3)-
  • Radiopharmaceuticals
  • 90Y-octreotide, DOTA-Tyr(3)-
  • Octreotide